WO2009006299A3 - Systèmes à multiples particules - Google Patents

Systèmes à multiples particules Download PDF

Info

Publication number
WO2009006299A3
WO2009006299A3 PCT/US2008/068574 US2008068574W WO2009006299A3 WO 2009006299 A3 WO2009006299 A3 WO 2009006299A3 US 2008068574 W US2008068574 W US 2008068574W WO 2009006299 A3 WO2009006299 A3 WO 2009006299A3
Authority
WO
WIPO (PCT)
Prior art keywords
particulate systems
particles
substance
coated
contain
Prior art date
Application number
PCT/US2008/068574
Other languages
English (en)
Other versions
WO2009006299A2 (fr
Inventor
Venkateswarlu Vobalaboina
Ezhil Arasan Ramanan
Venkat Arvind Vakati
Deshpande Mangesh
Nookaraju Venkata Sreedharala
Sarveswara Rao Srirama Mandavilli
Original Assignee
Reddys Lab Ltd Dr
Reddys Lab Inc Dr
Venkateswarlu Vobalaboina
Ezhil Arasan Ramanan
Venkat Arvind Vakati
Deshpande Mangesh
Nookaraju Venkata Sreedharala
Mandavilli Sarveswara Rao Srir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr, Reddys Lab Inc Dr, Venkateswarlu Vobalaboina, Ezhil Arasan Ramanan, Venkat Arvind Vakati, Deshpande Mangesh, Nookaraju Venkata Sreedharala, Mandavilli Sarveswara Rao Srir filed Critical Reddys Lab Ltd Dr
Publication of WO2009006299A2 publication Critical patent/WO2009006299A2/fr
Publication of WO2009006299A3 publication Critical patent/WO2009006299A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des compositions pharmaceutiques orales qui comprennent une pluralité de particules comprenant un ingrédient actif, les particules étant enrobées par ou contenant un composant bioadhésif et ayant des enrobages externes comprenant une substance qui se dissout dans des conditions de pH prédéterminées.
PCT/US2008/068574 2007-06-29 2008-06-27 Systèmes à multiples particules WO2009006299A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US94702007P 2007-06-29 2007-06-29
US60/947,020 2007-06-29
US95000007P 2007-07-16 2007-07-16
US60/950,000 2007-07-16

Publications (2)

Publication Number Publication Date
WO2009006299A2 WO2009006299A2 (fr) 2009-01-08
WO2009006299A3 true WO2009006299A3 (fr) 2009-02-19

Family

ID=40226782

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/068574 WO2009006299A2 (fr) 2007-06-29 2008-06-27 Systèmes à multiples particules

Country Status (1)

Country Link
WO (1) WO2009006299A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2874817T3 (es) * 2010-04-15 2021-11-05 Shin Nippon Biomedical Laboratories Ltd Procedimiento para generar una formulación de vacuna en polvo seco para suministro intranasal
CN103565751A (zh) * 2013-10-17 2014-02-12 广州帝奇医药技术有限公司 一种长效缓释微丸及其制备方法
JP6339800B2 (ja) * 2013-12-27 2018-06-06 株式会社三和化学研究所 ミグリトール含有コーティング製剤
EP4062907A1 (fr) * 2021-03-23 2022-09-28 Substipharm Formulation par voie orale d'ivermectine et utilisations

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003670A1 (fr) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Compositions de paroxetine a liberation controlee
WO2001052816A2 (fr) * 2000-01-19 2001-07-26 Carlsbad Technology, Inc. Formulations pharmaceutiques de derives benzimidazole administrees par voie orale et procede de preparation de ces dernieres
WO2003013480A1 (fr) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Preparation enterique de fluoxetine
WO2004045589A1 (fr) * 2002-11-15 2004-06-03 Elan Pharmaceuticals, Inc. Composition a liberation modifiee comprenant un hypnotique a action breve, destinee au traitement des troubles du sommeil
WO2004056336A2 (fr) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Systemes d'administration de medicaments a unites multiples et a liberation controlee
WO2005044240A2 (fr) * 2003-10-31 2005-05-19 Dexcel, Ltd. Formulation stable contenant du lansoprazole

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003670A1 (fr) * 1995-07-20 1997-02-06 Smithkline Beecham P.L.C. Compositions de paroxetine a liberation controlee
WO2001052816A2 (fr) * 2000-01-19 2001-07-26 Carlsbad Technology, Inc. Formulations pharmaceutiques de derives benzimidazole administrees par voie orale et procede de preparation de ces dernieres
WO2003013480A1 (fr) * 2001-08-06 2003-02-20 Dr. Reddy's Laboratories Ltd. Preparation enterique de fluoxetine
WO2004045589A1 (fr) * 2002-11-15 2004-06-03 Elan Pharmaceuticals, Inc. Composition a liberation modifiee comprenant un hypnotique a action breve, destinee au traitement des troubles du sommeil
WO2004056336A2 (fr) * 2002-12-20 2004-07-08 Ranbaxy Laboratories Limited Systemes d'administration de medicaments a unites multiples et a liberation controlee
WO2005044240A2 (fr) * 2003-10-31 2005-05-19 Dexcel, Ltd. Formulation stable contenant du lansoprazole

Also Published As

Publication number Publication date
WO2009006299A2 (fr) 2009-01-08

Similar Documents

Publication Publication Date Title
WO2006104894A3 (fr) Enrobage pour dispositifs implantables et leur methode de formation
WO2005101983A3 (fr) Systeme a retention gastrique
EP2081550A4 (fr) Revêtement de capsules avec des ingrédients pharmaceutiques actifs
WO2006099514A3 (fr) Composition d'administration de medicaments contenant un polymere et un agent modificateur
WO2006008739A3 (fr) Surfaces a conduction modifiee presentant des substances actives fixees a celles-ci et utilisations associees
WO2008132712A3 (fr) Compositions pharmaceutiques combinées
WO2010064126A3 (fr) Formes galéniques à libération contrôlée
EP1776225A4 (fr) Encapsulation de nanostructures apres deposition: compositions, dispositifs et systemes integrant lesdites nanostructures
WO2009117130A3 (fr) Formulation à libération prolongée contenant une cire
WO2012022919A3 (fr) Formulations à base de nalbuphine et leurs utilisations
EP3967695A4 (fr) Composé quinazoline et son application pharmaceutique
WO2007064895A3 (fr) Compositions polymeres, revetements et dispositifs, et procedes de fabrication et d'utilisation de ceux-ci
WO2011084760A3 (fr) Compositions d'enrobage du type particulaire, confiserie enrobée, et procédés de réalisation associés
EP2177235A3 (fr) Compositions de revêtement
WO2009048645A3 (fr) Revêtements lipidiques pour des dispositifs médicaux implantables
WO2008042748A3 (fr) Milieux polyélectrolytiques destinés à la distribution d'agents bioactifs
WO2009019477A3 (fr) Revêtement
EP2386295A3 (fr) Comprimes a liberation gastro-intestinale du principe actif regulee en foction du temps et du site
EP3958846A4 (fr) Compositions de médicaments enrobés et leurs procédés de préparation
WO2009106824A3 (fr) Formulations pharmaceutiques
WO2007092043A3 (fr) Systemes de liberation de materiau bioactif comprenant des compositions sol-gel
EP2180024A4 (fr) Composition filmogène hydrophile, composition de pulvérisation et élément hydrophile utilisant celle-ci
EP3694330A4 (fr) Dérivés d'indazolyl-spiro [2.2]pentane-carbonitrile en tant qu'inhibiteurs de lrrk2, compositions pharmaceutiques et leurs utilisations
EP3694331A4 (fr) Dérivés d'indazolyl-spiro [2,3]hexane-carbonitrile comme inhibiteurs de lrrk2, compositions pharmaceutiques, et utilisations de ceux-ci
WO2008051564A3 (fr) Formes cristallines d'hydrochlorure de palonosetron

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08772161

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 7392/CHENP/2009

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08772161

Country of ref document: EP

Kind code of ref document: A2